Imagene AI
Save to shortlistLast reviewed Oct 31, 2026 against the sources listed on this page · How we review
At a glance
Imagene AI is a precision medicine platform focused on biomarker discovery, H&E-based biomarker profiling, and companion diagnostic development in oncology.
- FDA:
- Not on record
- Epic:
- Not on record
- Named users:
- 1 named in public reports
- Published study:
- Not on record
Description
Imagene AI is a precision medicine platform focused on biomarker discovery, H&E-based biomarker profiling, and companion diagnostic development in oncology. It is intended for pharma, biotech, and clinical development teams working on translational research, trial assay development, and patient selection strategies.
Quick answers
Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review
- Which health systems use Imagene AI?
- Linked public reports name one organization: Tel Aviv Sourasky Medical Center. "Who's using this" below lists them all, plus any the maker reports. Ask the vendor for a reference at an organization like yours.Tel Aviv Sourasky Medical Center (The Jerusalem Post)
Security & contracting
The maker has not reported these details yet. Ask the vendor directly during evaluation.
- Workflow stage
- Not reported
- Integrations
- Not reported
- Data inputs
- Not reported
- Deployment
- Not reported
- Signs a BAA
- Not reported
- SOC 2 report
- Not reported
- HITRUST
- Not reported
- Evidence type
- Not assessed
Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.
Who's using this
1 organizationOrganizations named in public announcements or by the developer. Inclusion is not an endorsement.
Tel Aviv Sourasky Medical Center
“Tel Aviv Sourasky Medical Center implements Israeli startup Imagene AI’s revolution” — The Jerusalem Post, Nov 2022
Last checked Oct 31, 2026. Spot an error? Let us know through the discussion below.
Get weekly updates for Drug Discovery
Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.
Sources
This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.
WebsiteHistory (2)Show
Dated events on this listing's public record, newest first.
- Oct 31, 2026
Added to CIFoundry
- Nov 7, 2022
News report names Tel Aviv Sourasky Medical Center as a user (The Jerusalem Post)source
Developer
Imagene AI
Evaluating this tool?
Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.
Prepare evaluation packetChecklist for your role: Admin · Physician · IT · Compliance
Compare similar tools →